Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir.

Rockwood N, Mandalia S, Bower M, Gazzard B, Nelson M.
Publication year: 2011
External Link

Rockwood N, Mandalia S, Bower M, Gazzard B, Nelson M. Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir. AIDS Lond Engl. 2011 Aug 24;25(13):1671–3.

Leave a Reply

Your email address will not be published. Required fields are marked *